Published in Women's Health Weekly, March 30th, 1998
Advisors to the U.S. Food and Drug Administration (FDA) recommended on March 19, 1998, that the government approve the drug Xeloda, though they emphasized that the pill's usefulness is still largely unknown. Early suggestions that it could help shrink tumors by half among some women who have failed other therapies prompted the panel to back sale of the drug while its true effectiveness is still being studied.
"This is a fairly decent response rate," said Dr. Sandra Swain of the Comprehensive Breast...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.